Utilization of palliative care consultations in pediatric oncology phase I clinical trials

Andrea Cuviello; Renee Boss; Nirali Shah; Haven Battles; Andrea Beri; Lori Wiener

doi:10.1002/pbc.27771

Utilization of palliative care consultations in pediatric oncology phase I clinical trials

Andrea Cuviello, Renee Boss, Nirali Shah, Haven Battles, Andrea Beri, Lori Wiener

School of Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Pediatric phase I clinical oncology trials represent a unique cohort of patients who have not responded to standard therapies and remain highly vulnerable to treatment toxicity and/or disease burden. Incorporating a palliative care consultation into the care plan for those with relapsed/refractory cancer where chance of cure is limited is generally recommended. A retrospective chart review of pediatric phase I trials revealed that palliative care was consulted in <20% of patients, most often for symptom management. Efforts to increase the use of palliative services in this population may enhance quality of life for children and families enrolled in phase I studies.

Original language	English (US)
Article number	e27771
Journal	Pediatric Blood and Cancer
Volume	66
Issue number	8
DOIs	https://doi.org/10.1002/pbc.27771
State	Published - Aug 2019

Keywords

palliative care
pediatric oncology
phase I trial
quality of life
symptom management

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.27771

Cite this

@article{ec69f2f2e06a4f4c93cb575036e95430,

title = "Utilization of palliative care consultations in pediatric oncology phase I clinical trials",

abstract = "Pediatric phase I clinical oncology trials represent a unique cohort of patients who have not responded to standard therapies and remain highly vulnerable to treatment toxicity and/or disease burden. Incorporating a palliative care consultation into the care plan for those with relapsed/refractory cancer where chance of cure is limited is generally recommended. A retrospective chart review of pediatric phase I trials revealed that palliative care was consulted in <20% of patients, most often for symptom management. Efforts to increase the use of palliative services in this population may enhance quality of life for children and families enrolled in phase I studies.",

keywords = "palliative care, pediatric oncology, phase I trial, quality of life, symptom management",

author = "Andrea Cuviello and Renee Boss and Nirali Shah and Haven Battles and Andrea Beri and Lori Wiener",

note = "Funding Information: early clinical trials. This work is supported in part by the Intramural Research Programs of the NIH, National Cancer Institute, Center for Cancer Research. Publisher Copyright: {\textcopyright} 2019 Wiley Periodicals, Inc.",

year = "2019",

month = aug,

doi = "10.1002/pbc.27771",

language = "English (US)",

volume = "66",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "8",

}

TY - JOUR

T1 - Utilization of palliative care consultations in pediatric oncology phase I clinical trials

AU - Cuviello, Andrea

AU - Boss, Renee

AU - Shah, Nirali

AU - Battles, Haven

AU - Beri, Andrea

AU - Wiener, Lori

N1 - Funding Information: early clinical trials. This work is supported in part by the Intramural Research Programs of the NIH, National Cancer Institute, Center for Cancer Research. Publisher Copyright: © 2019 Wiley Periodicals, Inc.

PY - 2019/8

Y1 - 2019/8

N2 - Pediatric phase I clinical oncology trials represent a unique cohort of patients who have not responded to standard therapies and remain highly vulnerable to treatment toxicity and/or disease burden. Incorporating a palliative care consultation into the care plan for those with relapsed/refractory cancer where chance of cure is limited is generally recommended. A retrospective chart review of pediatric phase I trials revealed that palliative care was consulted in <20% of patients, most often for symptom management. Efforts to increase the use of palliative services in this population may enhance quality of life for children and families enrolled in phase I studies.

AB - Pediatric phase I clinical oncology trials represent a unique cohort of patients who have not responded to standard therapies and remain highly vulnerable to treatment toxicity and/or disease burden. Incorporating a palliative care consultation into the care plan for those with relapsed/refractory cancer where chance of cure is limited is generally recommended. A retrospective chart review of pediatric phase I trials revealed that palliative care was consulted in <20% of patients, most often for symptom management. Efforts to increase the use of palliative services in this population may enhance quality of life for children and families enrolled in phase I studies.

KW - palliative care

KW - pediatric oncology

KW - phase I trial

KW - quality of life

KW - symptom management

UR - http://www.scopus.com/inward/record.url?scp=85064642912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064642912&partnerID=8YFLogxK

U2 - 10.1002/pbc.27771

DO - 10.1002/pbc.27771

M3 - Article

C2 - 31012246

AN - SCOPUS:85064642912

SN - 1545-5009

VL - 66

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 8

M1 - e27771

ER -

Utilization of palliative care consultations in pediatric oncology phase I clinical trials

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this